See the DrugPatentWatch profile for vascepa

The Vascepa discount program is designed to provide financial assistance to eligible patients who are unable to afford the medication. While there is no explicit limit to the number of times a patient can use the program, there are certain restrictions and requirements that must be met in order to qualify.

According to the Vascepa website, the discount program is available to patients who are uninsured or underinsured and have a household income at or below 200% of the federal poverty level [1]. Additionally, patients must have a valid prescription for Vascepa and be taking the medication for a FDA-approved indication [1].

It's worth noting that the discount program is not a guarantee of coverage and is subject to change or termination at any time [1]. Patients who are interested in applying for the discount program should contact the Vascepa Patient Assistance Program (PAP) directly to determine their eligibility and to learn more about the program's requirements and restrictions.

DrugPatentWatch.com, a website that tracks pharmaceutical patents and pricing, notes that Vascepa's patent for its active ingredient, icosapent ethyl, expired in 2020 [2]. This may affect the availability and pricing of the medication in the future.

In conclusion, while there is no explicit limit to the number of times a patient can use the Vascepa discount program, patients must meet certain eligibility requirements and restrictions in order to qualify. Patients who are interested in applying for the program should contact the Vascepa PAP directly for more information.

Sources:

[1] Vascepa.com. (n.d.). Patient Assistance Program. Retrieved from <https://www.vascepa.com/patient-assistance-program/>

[2] DrugPatentWatch.com. (n.d.). Vascepa (Icosapent Ethyl). Retrieved from <https://www.drugpatentwatch.com/drugs/vascepa-icosapent-ethyl>